Breaking News
Tell General Mills To Reject GMO Wheat!
Climate Scientists declare the climate "emergency" is over
Trump's Cabinet is Officially Complete - Meet the Team Ready to Make America Great Again
Former Polish Minister: At Least Half of US Aid Was Laundered by Ukrainians...
Top Tech News
Forget Houston. This Space Balloon Will Launch You to the Edge of the Cosmos From a Floating...
SpaceX and NASA show off how Starship will help astronauts land on the moon (images)
How aged cells in one organ can cause a cascade of organ failure
World's most advanced hypergravity facility is now open for business
New Low-Carbon Concrete Outperforms Today's Highway Material While Cutting Costs in Minnesota
Spinning fusion fuel for efficiency and Burn Tritium Ten Times More Efficiently
Rocket plane makes first civil supersonic flight since Concorde
Muscle-powered mechanism desalinates up to 8 liters of seawater per hour
Student-built rocket breaks space altitude record as it hits hypersonic speeds
Researchers discover revolutionary material that could shatter limits of traditional solar panels
Scientists claim they've completed the first successful gene therapy against human ageing
The CEO of Bioviva USA Inc, Elizabeth Parrish, claims to be the first human in world history to have successfully reversed the effects of natural ageing - thanks to experimental gene therapy provided by her company.
Parrish first underwent gene therapy in 2015 - one designed to protect against muscle mass depletion that is inherent to ageing and another to fight stem cell depletion due to age-related diseases.
Originally meant to prove that her company's gene therapy was safe, the results - should they prove to be effective in the long-term and withstand due scientific scrutiny - would be the very first successful demonstration of telomere lengthening in any human.
"Current therapeutics offer only marginal benefits for people suffering from diseases of ageing. Additionally, lifestyle modification has limited impact for treating these diseases. Advances in biotechnology is the best solution, and if these results are anywhere near accurate, we've made history," Parrish notes.